Correlation Between Neurosense Therapeutics and Qilian International
Can any of the company-specific risk be diversified away by investing in both Neurosense Therapeutics and Qilian International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurosense Therapeutics and Qilian International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurosense Therapeutics and Qilian International Holding, you can compare the effects of market volatilities on Neurosense Therapeutics and Qilian International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurosense Therapeutics with a short position of Qilian International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurosense Therapeutics and Qilian International.
Diversification Opportunities for Neurosense Therapeutics and Qilian International
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Neurosense and Qilian is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Neurosense Therapeutics and Qilian International Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qilian International and Neurosense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurosense Therapeutics are associated (or correlated) with Qilian International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qilian International has no effect on the direction of Neurosense Therapeutics i.e., Neurosense Therapeutics and Qilian International go up and down completely randomly.
Pair Corralation between Neurosense Therapeutics and Qilian International
Given the investment horizon of 90 days Neurosense Therapeutics is expected to under-perform the Qilian International. But the stock apears to be less risky and, when comparing its historical volatility, Neurosense Therapeutics is 1.02 times less risky than Qilian International. The stock trades about -0.55 of its potential returns per unit of risk. The Qilian International Holding is currently generating about -0.12 of returns per unit of risk over similar time horizon. If you would invest 784.00 in Qilian International Holding on August 28, 2024 and sell it today you would lose (80.00) from holding Qilian International Holding or give up 10.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurosense Therapeutics vs. Qilian International Holding
Performance |
| Timeline |
| Neurosense Therapeutics |
| Qilian International |
Neurosense Therapeutics and Qilian International Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurosense Therapeutics and Qilian International
The main advantage of trading using opposite Neurosense Therapeutics and Qilian International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurosense Therapeutics position performs unexpectedly, Qilian International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qilian International will offset losses from the drop in Qilian International's long position.| Neurosense Therapeutics vs. Eliem Therapeutics | Neurosense Therapeutics vs. HCW Biologics | Neurosense Therapeutics vs. Scpharmaceuticals | Neurosense Therapeutics vs. Milestone Pharmaceuticals |
| Qilian International vs. Capricor Therapeutics | Qilian International vs. Soleno Therapeutics | Qilian International vs. Bio Path Holdings | Qilian International vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |